In addition, EDNRB and KIT were used as clinical drug targets for treatment of metastatic melanoma and so was NAMPT in gastric cancer.31–33 These results demonstrate that most of the genes in this classifier, which distinguishes melanoma from naevi, are involved in melanoma and cancer. Here, EDNRB is linked to metastatic melanoma.